Resource Center
Resource Center
New evidence from the Catalytic Opportunity Fund on pooled, rapid financing for reproductive health product introduction in low- and middle-income countries.
Read more
Unitaid and CHAI brought together more than 80 organizations from 28 countries for the Future of HIV Markets Forum, held in Nairobi, in June 2026. We've put together a report with the actions this group has committed to.
Read more
CHAI is pleased to release Lessons from a decade of progress: reigniting momentum for hepatitis C elimination, a new report marking ten years of CHAI-supported hepatitis C programs in Cambodia, India, Indonesia, Myanmar, Nigeria, Rwanda, and Vietnam. Since 2016, these programs have screened 25.4 million people, cured an estimated 473,000, and helped drive the cost of a complete cure down by over 88 percent.
Read more
CHAI and Renaissance Philanthropy have published a TPP that defines what an affordable, point-of-care blood lead screening test should deliver, to accelerate the development of tools that can close a major testing gap.
Read more
CHAI is pleased to release the 2026 Hepatitis C Treatment Market Memo, the latest in our series of hepatitis C market intelligence publications. A decade ago, curing hepatitis C cost more than US$84,000 per patient. Today, the same cure can be procured at around US$60 per patient. Few global health markets have changed so dramatically....
Read more
Updated analysis from CHAI tracks the state of African vaccine manufacturing ambitions in 2026 Africa has long relied on other parts of the world for its vaccines, a vulnerability COVID-19 made impossible to ignore. That crisis galvanized African leaders and international partners to act, prompting the creation of the Partnerships for African Vaccine Manufacturing (PAVM)...
Read more
New CHAI data from 2025 into early 2026: HIV testing, treatment, and prevention have shown little recovery from global funding cuts. Read the June 2026 memo.
Read more
How is lenacapavir PrEP rolling out globally? CHAI and WIts RHI track progress in early adopter countries and the path to generic market entry.
Read more
This toolkit provides practical guidance to integrate hepatitis, harm reduction, and triple elimination into HIV programs in ways that are policy-aligned, defensible, and scalable.
Read more
New modeling by Imperial College and MAP estimates PMI's malaria impact across sub-Saharan Africa: 379 million cases and 1.1 million deaths averted from 2005–2024.
Read more